OVERTURE HEALTH UK LTD - BASINGSTOKE
Company Profile | Company Filings |
Overview
OVERTURE HEALTH UK LTD is a Private Limited Company from BASINGSTOKE UNITED KINGDOM and has the status: Active.
OVERTURE HEALTH UK LTD was incorporated 1 years ago on 09/08/2022 and has the registered number: 14286255. The accounts status is NO ACCOUNTS FILED and accounts are next due on 09/05/2024.
OVERTURE HEALTH UK LTD was incorporated 1 years ago on 09/08/2022 and has the registered number: 14286255. The accounts status is NO ACCOUNTS FILED and accounts are next due on 09/05/2024.
OVERTURE HEALTH UK LTD - BASINGSTOKE
This company is listed in the following categories:
62012 - Business and domestic software development
62012 - Business and domestic software development
62020 - Information technology consultancy activities
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 8 | 09/05/2024 |
Registered Office
5 CROSSBOROUGH GARDENS
BASINGSTOKE
HAMPSHIRE
RG21 4LB
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
13/01/2024 | 27/01/2025 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR DUNCAN JOHN WELLING | Nov 1983 | English | Director | 2022-08-09 | CURRENT |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Choir Consulting Ltd | 2022-08-09 - 2022-08-09 | Basingstoke |
Ownership of shares 25 to 50 percent Voting rights 50 to 75 percent |
|
Michael Christian Mrochen | 2022-08-09 | 1/1971 | Basingstoke |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Mr Duncan John Welling | 2022-08-09 | 11/1983 | Alresford | Significant influence or control |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Overture Health UK Ltd - Accounts to registrar (filleted) - small 23.2.5 | 2024-04-02 | 31-08-2023 | £1,000 equity |